TNFRSF1A

From Wikipedia, the free encyclopedia


Tumor necrosis factor receptor superfamily, member 1A
PDB rendering based on 1ext.
Available structures: 1ext, 1ft4, 1ich, 1ncf, 1tnr
Identifiers
Symbol(s) TNFRSF1A; p55; TBP1; CD120a; FPF; MGC19588; TNF-R; TNF-R-I; TNF-R55; TNFAR; TNFR1; TNFR55; TNFR60; p55-R; p60
External IDs OMIM: 191190 MGI1314884 HomoloGene828
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 7132 21937
Ensembl ENSG00000067182 ENSMUSG00000030341
Uniprot P19438 Q3TVS9
Refseq NM_001065 (mRNA)
NP_001056 (protein)
NM_011609 (mRNA)
NP_035739 (protein)
Location Chr 12: 6.31 - 6.32 Mb Chr 6: 125.32 - 125.33 Mb
Pubmed search [1] [2]

Tumor necrosis factor receptor superfamily, member 1A, also known as TNFRSF1A or CD120A, is a human gene. The protein encoded by this gene is a member of the Tumor necrosis factor receptor superfamily, which also contains TNFRSF1B. This protein is one of the major receptors for the tumor necrosis factor-alpha. This receptor can activate the transcription factor NF-kB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the signal transduction mediated by the receptor. Germline mutations of the extracellular domains of this receptor were found to be associated with the human genetic disorder called periodic fever syndrome. Impaired receptor clearance is thought to be a mechanism of the disease.[1]

Contents

[edit] See also

[edit] References

[edit] Further reading

  • Rath PC, Aggarwal BB (2000). "TNF-induced signaling in apoptosis.". J. Clin. Immunol. 19 (6): 350–64. PMID 10634209. 
  • Chen G, Goeddel DV (2002). "TNF-R1 signaling: a beautiful pathway.". Science 296 (5573): 1634–5. doi:10.1126/science.1071924. PMID 12040173. 
  • Kollias G, Kontoyiannis D (2003). "Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.". Cytokine Growth Factor Rev. 13 (4-5): 315–21. PMID 12220546. 
  • Dodé C, Cuisset L, Delpech M, Grateau G (2003). "TNFRSF1A-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS) and renal amyloidosis.". J. Nephrol. 16 (3): 435–7. PMID 12832748. 
  • Stojanov S, McDermott MF (2007). "The tumour necrosis factor receptor-associated periodic syndrome: current concepts.". Expert reviews in molecular medicine 7 (22): 1–18. doi:10.1017/S1462399405009749. PMID 16216134. 
  • Rezaei N (2007). "TNF-receptor-associated periodic syndrome (TRAPS): an autosomal dominant multisystem disorder.". Clin. Rheumatol. 25 (6): 773–7. doi:10.1007/s10067-005-0198-6. PMID 16447098. 

[edit] External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.